Radiopharm Theranostics Ltd (ASX:RAD, OTC:RDPTF) has received valid applications under an entitlement offer to raise A$2.1 million in funding, the equivalent of more than 30 million shares at the issue price of $0.07 per new share.
“I would like to thank shareholders who have participated in the rights issue. The funds raised will go towards supporting our prioritised programs,” RAD managing director Riccardo Canevari said.